Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; and Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, tonics, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.
Consun Pharmaceutical Dividend Announcement
• Consun Pharmaceutical announced a semi annually dividend of HK$0.30 per ordinary share which will be made payable on 2024-09-20. Ex dividend date: 2024-09-05
• Consun Pharmaceutical annual dividend for 2024 was HK$0.60
• Consun Pharmaceutical annual dividend for 2023 was HK$0.45
• Consun Pharmaceutical's trailing twelve-month (TTM) dividend yield is 9.64%
• Consun Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 67.96%
• Consun Pharmaceutical's dividend growth over the last five years (2018-2023) was 35.10% year
Consun Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-05 | HK$0.30 | semi annually | 2024-09-20 |
2024-06-11 | HK$0.30 | semi annually | 2024-06-21 |
2023-09-07 | HK$0.15 | semi annually | 2023-09-20 |
2023-06-08 | HK$0.30 | semi annually | 2023-06-21 |
2022-06-02 | HK$0.20 | semi annually | 2022-06-17 |
2021-09-08 | HK$0.10 | semi annually | 2021-09-23 |
2021-09-01 | HK$0.10 | semi annually | |
2021-05-28 | HK$0.20 | semi annually | 2021-06-11 |
2020-09-02 | HK$0.08 | semi annually | 2020-09-16 |
2020-06-05 | HK$0.10 | semi annually | 2020-06-19 |
2019-09-02 | HK$0.10 | semi annually | 2019-09-17 |
2019-06-06 | HK$0.20 | semi annually | 2019-06-21 |
2019-05-31 | HK$0.20 | semi annually | |
2018-06-01 | HK$0.10 | semi annually | 2018-06-15 |
2017-09-06 | HK$0.10 | semi annually | 2017-09-29 |
2017-06-02 | HK$0.05 | semi annually | 2017-06-16 |
2017-05-05 | HK$0.10 | semi annually | 2017-05-19 |
2017-04-21 | HK$0.10 | semi annually | |
2016-09-14 | HK$0.05 | semi annually | 2016-09-28 |
2016-05-31 | HK$0.09 | semi annually | 2016-06-16 |
2015-06-03 | HK$0.04 | semi annually | 2015-06-22 |
2014-09-25 | HK$0.04 | semi annually | 2014-10-15 |
Consun Pharmaceutical Dividend per year
Consun Pharmaceutical Dividend growth
Consun Pharmaceutical Dividend Yield
Consun Pharmaceutical current trailing twelve-month (TTM) dividend yield is 9.64%. Interested in purchasing Consun Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Consun Pharmaceutical Financial Ratios
Consun Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Consun Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Consun Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Consun Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Consun Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Consun Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Consun Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Consun Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Consun Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Consun Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Consun Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Consun Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.